BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28780306)

  • 1. Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins.
    Yeo CE; Kang WY; Seong SJ; Cho S; Lee HW; Yoon YR; Kim HJ
    Exp Cell Res; 2017 Oct; 359(1):112-119. PubMed ID: 28780306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.
    Kim MY; Lee K; Shin HI; Jeong D
    Sci Rep; 2019 May; 9(1):7044. PubMed ID: 31065073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin-like 1 promotes osteoclast formation via RANKL-mediated NF-κB activation and M-CSF-induced precursor proliferation.
    Kim HJ; Kang WY; Seong SJ; Kim SY; Lim MS; Yoon YR
    Cell Signal; 2016 Sep; 28(9):1137-1144. PubMed ID: 27234130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
    Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src-like adaptor protein regulates osteoclast generation and survival.
    Kim HJ; Zou W; Ito Y; Kim SY; Chappel J; Ross FP; Teitelbaum SL
    J Cell Biochem; 2010 May; 110(1):201-9. PubMed ID: 20225239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts.
    Saito H; Nakamachi T; Inoue K; Ikeda R; Kitamura K; Minamino N; Shioda S; Miyata A
    J Endocrinol; 2013 May; 217(2):141-50. PubMed ID: 23428580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rab11A Functions as a Negative Regulator of Osteoclastogenesis through Dictating Lysosome-Induced Proteolysis of c-fms and RANK Surface Receptors.
    Okusha Y; Tran MT; Itagaki M; Sogawa C; Eguchi T; Okui T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANGPTL2 deletion inhibits osteoclast generation by modulating NF-κB/MAPKs/Cyclin pathways.
    Li WM; Han CL; Liu C; Xing HY; Ding DC
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1471-1477. PubMed ID: 30031603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
    Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
    J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.
    Amano S; Sekine K; Bonewald LF; Ohmori Y
    J Cell Physiol; 2009 Oct; 221(1):40-53. PubMed ID: 19492422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.
    González N; Nakagawa T; Mantey SA; Sancho V; Uehara H; Katsuno T; Jensen RT
    J Pharmacol Exp Ther; 2009 Oct; 331(1):265-76. PubMed ID: 19628633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro.
    Marahleh A; Kitaura H; Ishida M; Shima K; Kishikawa A; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Nara Y; Mizoguchi I
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromedin B receptor mediates neuromedin B-induced COX-2 and IL-6 expression in human primary myometrial cells.
    Chen J; Shi Y; Huang J; Luo J; Zhang W
    J Investig Med; 2020 Aug; 68(6):1171-1178. PubMed ID: 32699178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.